Hong Fang Song is Director at CG Oncology, Inc. (CGON). They have made 4 open-market trades across 1 company since 2024, most recently 2025-09-03.
CIK 0002008157
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2024, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CGON | 2,903,931 | $173.8M |
Shares reported on the most recent Form 4, priced at the 2025-09-04 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.